Impact of TRIPS in India
Subtitle: an access to medicines perspective
By: Prabodh Malhotra
Contributors: Palgrave Connect (Online service)
Publisher: Palgrave Macmillan
Published: 2010
Place of publication: Basingstoke, Hampshire; New York
Language: eng
Format: [electronic resource] :
Number of pages: 320
ISBN-13: 9780230290747; 9780230272781
Subjects: Industries; Drug Industry; Patents as Topic; Health Services Accessibility; International Cooperation; Legislation & jurisprudence; Health services accessibility; India; Pharmaceutical industry; Agreement on Trade-Related Aspects of Intellectual Property Rights; (1994); Pharmaceutical policy; Pharmaceutical & Biotechnology; BUSINESS & ECONOMICS
Description: Over the last three decades, drug prices in India have declined from one of the highest to one of the lowest in the world. Yet, under the current healthcare model, only around 35 per cent of people in India have access to medicines. In the lead up to 2005, when TRIPS compliant regime was introduced in India, there were apprehensions about the drug prices rising under the new regime, which would further restrict access to medicine. This book examines the impact of TRIPS on drug prices and exports of drugs and pharmaceuticals in India. It goes on to develop a new healthcare model, which if implemented, would extend access to medicines to India's entire population. Sensitivity tests show that the proposed model is affordable, equitable and implementable, and can be replicated in other developing countries. This book is indispensable reading for all interested in development economics, intellectual property rights in developing countries, pharmaceutical markets and health systems.
Notes: Includes bibliographical references and index.

Description based on print version record.
Table of contents: title: Foreword; title: Acknowledgments; title: Introduction; title: PART I: INFLUENCE OF GLOBAL FORCES ON ACCESS TO MEDICINES; title: The World Trade Organization and the TRIPS Agreement; title: The Global Pharmaceutical Industry and Developing New Drugs; title: PART II: ACCESS TO MEDICINES IN INDIA; title: Development of India's Pharmaceutical Industry; title: TRIPS and the Indian Patents Regime; title: Price Controls and Drug Affordability in India: Policy Options; title: Health Insurance in India; title: Broadening the Access to Medicines and Healthcare in India; title: PART III: GLOBAL PERSPECTIVE; title: Is TRIPS Appropriate for Developing Countries?; title: Which Way Ahead?; title: Final Conclusions; title: References.